Company:  ANACOR PHARMACEUTICALS, I ... (ANAC)
Form Type:  10-Q
Filing Date:  11/9/2012 
CIK:  0001411158 
Address:  1020 E. MEADOW CIRCLE 
City, State, Zip:  PALO ALTO, California 94303 
Telephone:  650-543-7500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$16.45  
Change: 
-0.38 (-2.26%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$688.25M
Description of Business
We are a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from our boron chemistry platform. We have demonstrated that our organization, utilizing our boron chemistry platform, is highly productive and efficient at creating novel clinical product candidates. We have discovered, synthesized and developed eight molecules that are currently in development, and we believe that our organization and boron chemistry platform have the potential to continue to yield clinical candidates at a relatively constant rate and efficiency in the future. While drug development is often uncertain and occasionally uneven, our current portfolio of product candidates and our ability to efficiently fill our own pipeline provide us with a unique opportunity to create a valuable and sustainable biopharmaceutical company.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        BALANCE SHEET
        INCOME STATEMENT
        CASH FLOW
        Notes to Condensed Financial Statements
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1A. RISK FACTORS
      ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      ITEM 6. EXHIBITS
    SIGNATURES
    Exhibit Index
  EXHIBIT 4.19
  EXHIBIT 4.20
  EXHIBIT 31.1
    CERTIFICATION
  EXHIBIT 31.2
    CERTIFICATION
  EXHIBIT 32.1
    CERTIFICATION
BROKERAGE PARTNERS